Earnings Feed
Start Free
Home/Filings/4/0001140361-15-026581
4//SEC Filing

Raptor Pharmaceutical Corp 4

Accession 0001140361-15-026581

CIK 0001070698operating
View on SEC.govCompany Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:36 PM ET

Size

20.3 KB

Accession

0001140361-15-026581

Insider Transaction Report

Form 4
Period: 2015-07-01
Raptor Pharmaceutical CorpRPTP
Keltner Llew
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2015-07-01$3.54/sh+15,836$56,059→ 56,695 total
  • Sale

    Common Stock

    2015-07-01$16.05/sh−50,000$802,545→ 6,695 total
  • Exercise/Conversion

    Common Stock

    2015-07-01$3.30/sh+2,186$7,214→ 8,881 total
  • Exercise/Conversion

    Common Stock

    2015-07-01$2.02/sh+2,488$5,026→ 11,369 total
  • Exercise/Conversion

    Stock options (right to buy)

    2015-07-01−2,488→ 0 total
    Exercise: $2.02Exp: 2020-03-09→ Common Stock (2,488 underlying)
  • Exercise/Conversion

    Common Stock

    2015-07-01$2.97/sh+29,490$87,585→ 40,859 total
  • Exercise/Conversion

    Stock options (right to buy)

    2015-07-01−2,186→ 0 total
    Exercise: $3.30Exp: 2019-09-30→ Common Stock (2,186 underlying)
  • Exercise/Conversion

    Stock options (right to buy)

    2015-07-01−29,490→ 0 total
    Exercise: $2.97Exp: 2020-10-12→ Common Stock (29,490 underlying)
  • Exercise/Conversion

    Stock options (right to buy)

    2015-07-01−15,836→ 74,164 total
    Exercise: $3.54Exp: 2020-11-22→ Common Stock (15,836 underlying)
Footnotes (4)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 27, 2014.
  • [F2]Includes 5021 Restricted Stock Units ("RSUs") granted on May 19, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs vest in four equal quarterly installments with the final installment vesting no later than immediately prior to the 2016 annual meeting of stockholders.
  • [F3]This transaction was executed in multiple trades at prices ranging from $15.78 to $16.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]Fully vested and exercisable.

Documents

1 file

Issuer

Raptor Pharmaceutical Corp

CIK 0001070698

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070698

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:36 PM ET
Size
20.3 KB
View on SEC.gov